Bevacizumab: A Review of its Use in Metastatic Colorectal Cancer

ISSN： 0012-6667

Source： Drugs, Vol.68, Iss.4, 2008-01, pp. : 487-506

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Panitumumab: A Review of its Use in Metastatic Colorectal Cancer

By Keating Gillian M.

Drugs, Vol. 70, Iss. 8, 2010-05 ,pp. : 1059-1078

Adis International

Access to resources Recommend Favorite

Oxaliplatin: A Review of its Use in the Management of Metastatic Colorectal Cancer

By Wiseman L.R. Adkins J.C. Plosker G.L. Goa K.L.

Drugs & Aging, Vol. 14, Iss. 6, 1999-06 ,pp. : 459-475

Adis International

Access to resources Recommend Favorite

Capecitabine: A Review of its Use in the Treatment of Advanced or Metastatic Colorectal Cancer

By McGavin J.K. Goa K.L.

Drugs, Vol. 61, Iss. 15, 2001-01 ,pp. : 2309-2326

Adis International

Access to resources Recommend Favorite

Oxaliplatin: A Review of its Use in Combination Therapy for Advanced Metastatic Colorectal Cancer

By Simpson D. Dunn C. Curran M. Goa K.L.

Drugs, Vol. 63, Iss. 19, 2003-01 ,pp. : 2127-2156

Adis International

Access to resources Recommend Favorite

Bevacizumab: A Review of its Use in Combination with Paclitaxel or Capecitabine as First-Line Therapy for HER2-Negative Metastatic Breast Cancer

By Croom Katherine F. Dhillon Sohita

Drugs, Vol. 71, Iss. 16, 2011-11 ,pp. : 2213-2229

Adis International

Access to resources Recommend Favorite